“Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma With GEMCAP and MFOLFIRINOX Regimens: Adverse Events and Long-Term Outcomes”. 2026. Voprosy Onkologii 72 (1): OF-2421. https://doi.org/10.37469/0507-3758-2026-72-1-OF-2421.